← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

M

$ Value

Shares

12,875

Price

Filed

Apr 3

Insider

Name

Mazabraud Yann

Title

EVP, Head of International

CIK

0001774702

Roles

Officer

Transaction Details

Transaction Date

2026-04-01

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

66,030

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. | The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 1, 2026 and April 1, 2027. The restricted stock units have no expiration date. | The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 1, 2026, April 1, 2027 and April 1, 2028. The restricted stock units have no expiration date.

Filing Info

Accession No.

0001104659-26-039687

Form Type

4

Issuer CIK

0001649904

Mazabraud Yann's History

Date Ticker Type Value
2026-04-01 RYTM M
2026-04-01 RYTM M $0
2026-04-01 RYTM M $0
2026-02-01 RYTM M
2026-02-01 RYTM M $0
2025-04-29 RYTM $439K

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-01
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-01
Smith Hunter C
Chief Financial Officer
$703K 2026-02-05
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-01
Cramer Pamela J.
Chief Human Resources Officer
2026-02-01
Shulman Joseph
Chief Technical Officer
2026-02-01
Garfield Alastair
Chief Scientific Officer
2026-02-01